Descripción

Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.

Figure 4

Source Paper

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.

Clinical, cosmetic and investigational dermatology (2023)

PMID: 37284568

DOI: 10.2147/CCID.S385861

Cite This Figure

![Figure 4: Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.]()

> Source: Michael Kaiser et al. "Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.." *Clinical, cosmetic and investigational dermatology*, 2023. PMID: [37284568](https://pubmed.ncbi.nlm.nih.gov/37284568/)

<figure>
  <img src="" alt="Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments." />
  <figcaption>Figure 4. Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.<br>  Source: Michael Kaiser et al. "Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.." <em>Clinical, cosmetic and investigational dermatology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37284568/">37284568</a></figcaption>
</figure>

Evidencia relacionada

Minoxidil para Alopecia Androgenética

Calificación A · 299 estudios

Finasteride para Alopecia Androgenética

Calificación A · 206 estudios

Terapia Láser de Baja Intensidad para Alopecia Androgenética

Calificación A · 60 estudios

Microagujación para Alopecia Androgenética

Calificación A · 62 estudios

Terapia PRP para Alopecia Androgenética

Calificación A · 144 estudios

Spironolactone para Alopecia Androgenética

Calificación A · 45 estudios